These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3247276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients.
    Pitha J, Pitha J.
    J Pharm Sci; 1985 Sep; 74(9):987-90. PubMed ID: 4067854
    [Abstract] [Full Text] [Related]

  • 4. Complexation of several drugs with water-soluble cyclodextrin polymer.
    Szeman J, Ueda H, Szejtli J, Fenyvesi E, Machida Y, Nagai T.
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):282-8. PubMed ID: 3594657
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY, Tsai WY.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A structural study of the inclusion compound of piroxicam with beta-cyclodextrin by NMR].
    Miao ZC, Du ZH, Xu GF, Shi TS.
    Yao Xue Xue Bao; 1988 Apr; 23(9):682-7. PubMed ID: 3256202
    [No Abstract] [Full Text] [Related]

  • 12. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
    Szente L, Apostol I, Szejtli J.
    Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
    [Abstract] [Full Text] [Related]

  • 13. Quantitative structure-stability relationships among inclusion complexes of cyclodextrins. I: Barbituric acid derivatives.
    Lopata A, Darvas F, Stadler-Szóke A, Szejtli J.
    J Pharm Sci; 1985 Feb; 74(2):211-3. PubMed ID: 3989695
    [Abstract] [Full Text] [Related]

  • 14. Studies of cyclodextrin inclusion complexes: II--Inclusion complexes between alpha-cyclodextrin and N-desmethyldiazepam and chlordiazepoxide.
    Aboutaleb AE, Abdel Rahman A, Samy EM.
    J Pharm Belg; 1988 Feb; 43(6):437-44. PubMed ID: 3150006
    [No Abstract] [Full Text] [Related]

  • 15. Pharmaceutical usefulness of hydroxypropylcyclodextrins: "e pluribus unum" is an essential feature.
    Rao CT, Fales HM, Pitha J.
    Pharm Res; 1990 Jun; 7(6):612-5. PubMed ID: 2367328
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationships between crystallinity of beta-cyclodextrin and tablet characteristics.
    Nakai Y, Yamamoto K, Terada K, Kajiyama A.
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5110-2. PubMed ID: 3830437
    [No Abstract] [Full Text] [Related]

  • 18. Study of products containing mebendazole and beta-cyclodextrin.
    Kata M, Papp L.
    Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.